This inventor holds 1 USPTO granted patent. Top assignee: Regeneron Pharmaceuticals, Inc.. Active years: 2024.
Company Filing History:
Years Active: 2024
Title: Samit Ganguly: Innovator in COVID-19 Treatment
Introduction
Samit Ganguly is a notable inventor based in Elmsford, NY (US). He has made significant contributions to the field of medical science, particularly in the fight against COVID-19. His innovative work focuses on methods for treating and preventing SARS-CoV-2 infections.
Latest Patents
Samit Ganguly holds a patent titled "Methods for treating or preventing SARS-CoV-2 infections and COVID-19 with anti-SARS-CoV-2 spike glycoprotein antibodies." This invention provides methods for preventing and treating SARS-CoV-2 infections, COVID-19, or symptoms thereof. The methods feature the administration of one or more antigen-binding molecules, such as antibodies, that bind to a surface protein of SARS-CoV-2, specifically the spike protein. He has 1 patent to his name.
Career Highlights
Samit Ganguly is currently employed at Regeneron Pharmaceuticals, Inc., where he continues to work on groundbreaking research and development in the pharmaceutical industry. His role at the company allows him to collaborate with other talented professionals in the field.
Collaborations
Some of his notable coworkers include Eduardo Forleo Neto and Meagan P O'Brien. Their collective expertise contributes to the innovative environment at Regeneron Pharmaceuticals.
Conclusion
Samit Ganguly's work in developing methods for treating COVID-19 showcases his dedication to advancing medical science. His contributions are vital in the ongoing battle against the pandemic, and his innovative spirit continues to inspire others in the field.